Clinical Trials
3 trialsNCT03030417 2024-12-10
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01851369 2024-05-08
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00583323 2014-08-21
Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET
Mayo Clinic
Phase 3 Completed